CoChat

Expression of Different 17β-Hydroxysteroid Dehydrogenase Types and Their Activities in Human Prostate Cancer Cells*

Open access
Castagnetta, Luigi A. M., Carruba, Giuseppe, Traina, Adele, Granata, Orazia M., Markus, Monika, Pavone-Macaluso, Michele, Blomquist, Charles H., Adamski, Jerzy · 1997 · Endocrinology
Cited by 45

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

The 17beta-hydroxysteroid dehydrogenase (17betaHSD) enzyme system governs important redox reactions at the C17 position of steroid hormones. Different 17betaHSD types (no. 1-4) have been identified to date in peripheral human tissues, such as placenta, testis, and breast. However, there is little information on their expression and activity in either normal or malignant prostate. In the present work, we have inspected pathways of 17beta-oxidation of either androgen or estrogen in human prostate cancer cells (LNCaP, DU145, and PC3) in relation to the expression of messenger RNAs (mRNAs) for 17betaHSD types 1-4. These cell systems feature distinct steroid receptor status and response to hormones. We report here that high expression levels of 17betaHSD4 were consistently observed in all three cell lines, whereas even greater amounts of 17betaHSD2 mRNA were detected solely in PC3 cells. Neither 17betaHSD1 nor 17betaHSD3 mRNAs could be detected in any cell line. From a metabolic standpoint, intact cell analysis showed a much lower extent of 17beta-oxidation of both androgen [testosterone (T)] and estrogen [estradiol (E2)] in LNCaP and DU145 cells compared to PC3 cells, where a greater precursor degradation and higher formation rates of oxidized derivatives (respectively, androstenedione and estrone) were observed. Using subcellular fractionation, we have been able to differentiate among 17betaHSD types 1-4 on the basis of their distinct substrate specificities and subcellular localization. This latter approach gave rise to equivalent results. PC3 cells, in fact, displayed a high level of microsomal activity with a low E2/T activity ratio and approximately equal apparent Km values for E2 and T, suggesting the presence of 17betaHSD2. Dehydrogenase specific activity with both E2 and T was also detected, although at lower levels, in LNCaP and DU145 cells. No evidence for reductase activity could be obtained in either the soluble or microsomal fraction of any cell line. As comparable expression levels of 17betaHSD4 were seen in the three cell lines, 17betaHSD2 is a likely candidate to account for the predominant oxidative activity in PC3 cells, whereas 17betaHSD4 may account for the lower extent of E2 oxidation seen in both LNCaP and DU145 cells. This is the first report on the expression of four different 17betaHSD types in human prostate cancer cells. It ought to be emphasized that for the first time, analysis of different 17betaHSD activities in either intact or fractionated cells harmonizes with the expression of relevant mRNAs species.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/endo.138.11.5497

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 29

  1. Andersson, 1995, 17β-Hydroxysteroid dehydrogenases: isozymes and mutations., J Endocrinol, 146, 197, 10.1677/joe.0.1460197 · DOI · Paper page
  2. Reed, 1991, Oestradiol 17β-hydroxysteroid dehydrogenase: its family and function., J Endocrinol, 129, 163, 10.1677/joe.0.1290163 · DOI
  3. Luu-The, 1989, Characterization of cDNAs for human estradiol 17β-dehydrogenase and assignment of the gene to chromosome 17: evidence of two mRNA species with distinct 5′-termini in human placenta., Mol Endocrinol, 3, 1301, 10.1210/mend-3-8-1301 · DOI · Paper page
  4. Adamski, 1992, Purification and properties of oestradiol 17β-dehydrogenase extracted from cytoplasmic vesicles of porcine endometrial cells., Biochem J, 288, 375, 10.1042/bj2880375 · DOI · Paper page
  5. Leenders, 1994, The sequence of porcine 80 kDa 17β-estradiol dehydrogenase reveals similarities to the short chain alcohol dehydrogenase family, to actin binding motifs and to sterol carrier protein 2., Mol Cell Endocrinol, 104, 127, 10.1016/0303-7207(94)90114-7 · DOI
  6. Normand, 1995, Molecular characterization of mouse 17β-hydroxysteroid dehydrogenase IV., J Steroid Biochem Mol Biol, 55, 541, 10.1016/0960-0760(95)00204-9 · DOI
  7. Bartsch, 1990, Enzymes of androgen formation and degradation in the human prostate., Ann NY Acad Sci, 595, 53, 10.1111/j.1749-6632.1990.tb34282.x · DOI
  8. Klein, 1991, Endocrine-Dependent Tumors, 131
  9. Krieg, 1979, A comparative study of binding, metabolism and endogenous levels of androgens in normal, hyperplastic and carcinomatous human prostate., J Steroid Biochem, 11, 615, 10.1016/0022-4731(79)90090-6 · DOI
  10. D’Agostino, 1984, Solvent optimization for RP-HPLC of polar adrenal steroids using computer predicted retention for a modified COF procedure., J Chromatogr, 305, 13, 10.1016/S0378-4347(00)83310-1 · doi:10.1016/s0378-4347(00)83310-1
  11. D’Agostino, 1985, Computer-aided mobile phase optimization and chromatogram simulation in high-performance liquid chromatography., J Chromatogr, 338, 1, 10.1016/0378-4347(85)80065-7 · doi:10.1016/0378-4347(85)80065-7
  12. Castagnetta, 1991, Simple approach to measure metabolic pathways of steroids in living cells., J Chromatogr, 572, 25, 10.1016/0378-4347(91)80470-W · DOI
  13. Castagnetta, 1994, Different conversion metabolic rates of testosterone are associated to hormone-sensitive status and -response of human prostate cancer cells., J Steroid Biochem Mol Biol, 49, 351, 10.1016/0960-0760(94)90279-8 · doi:10.1016/0960-0760(94)90279-8
  14. Castagnetta, 1995, Oxidative and reductive pathways in hormone responsive and non-responsive human breast cancer cells in vitro., J Steroid Biochem Mol Biol, 53, 367, 10.1016/0960-0760(95)00081-A · doi:10.1016/0960-0760(95)00081-a
  15. Castagnetta, 1995, 17β-Hydroxysteroid dehydrogenase activity in endometrial cancer cells: different metabolic pathways of estradiol in hormone-responsive and non-responsive intact cells., J Steroid Biochem Mol Biol, 55, 573, 10.1016/0960-0760(95)00208-1 · doi:10.1016/0960-0760(95)00208-1
  16. Castagnetta, 1986, Estrone conversion rates by human endometrial cancer cell lines., J Steroid Biochem, 25, 803, 10.1016/0022-4731(86)90312-2 · doi:10.1016/0022-4731(86)90312-2
  17. Adams, 1988, Metabolic fate of estradiol in human mammary cancer cells in culture: estrogen sulfate formation and cooperativity exhibited by estrogen sulfotransferase., Mol Cell Endocrinol, 58, 231, 10.1016/0303-7207(88)90159-1 · DOI
  18. Blomquist, 1995, Properties and regulation of 17β-hydroxysteroid dehydrogenase oxidoreductase of OVCAR-3, CAOV-3 and A431 cells: effects of epidermal growth factor, estradiol and progesterone., J Cell Biochem, 59, 409, 10.1002/jcb.240590402 · DOI
  19. Blomquist, 1994, A comparison of 17β-hydroxysteroid oxidoreductase type 1 and type 2 activity of cytosol and microsomes from human term placenta, ovarian stroma and granulosa-luteal cells., J Steroid Biochem Mol Biol, 49, 183, 10.1016/0960-0760(94)90009-4 · DOI
  20. Markwell, 1981, Protein determination in membrane and lipoprotein samples: manual and automated procedures., Methods Enzymol, 72, 296, 10.1016/S0076-6879(81)72018-4 · DOI · Paper page
  21. Cornish-Bowden, 1978, Michaelis constant and maximum velocity from the direct linear plot., Biochim Biophys Acta, 523, 268, 10.1016/0005-2744(78)90030-X · DOI · Paper page
  22. Blomquist, 1995, Prediction of multiple forms of 17β-hydroxysteroid dehydrogenase., J Steroid Biochem Mol Biol, 55, 515, 10.1016/0960-0760(95)00200-6 · DOI
  23. Pylkkanen, 1996, Immunohistochemical localization of estrogen-specific 17β-hydroxysteroid oxidoreductase in the human and mouse prostate., Prostate, 25, 292, 10.1002/pros.2990250603 · doi:10.1002/pros.2990250603
  24. Delos, 1995, Testosterone metabolism in primary cultures of human prostate epithelial cells and fibroblasts., J Steroid Biochem Mol Biol, 55, 375, 10.1016/0960-0760(95)00184-0 · DOI
  25. Carruba, 1994, Steroid-growth factor interaction in human prostate cancer. I. Short-term effects of transforming growth factors on growth of human prostate cancer cells., Steroids, 59, 412, 10.1016/0039-128X(94)90010-8 · doi:10.1016/0039-128x(94)90010-8
  26. Castagnetta, 1995, Growth of LNCaP cells is stimulated by estradiol via its own receptor., Endocrinology, 136, 2309, 10.1210/endo.136.5.7536668 · doi:10.1210/endo.136.5.7536668
  27. Carstensen, 1996, Characterization of 17β-hydroxysteroid dehydrogenase IV, J Endocrinol [Suppl], 150, S3
  28. Bradlow, 1995, Effect of serum albumin on estrogen metabolism in human cancer cell lines., Mol Cell Endocrinol, 115, 221, 10.1016/0303-7207(95)03684-9 · doi:10.1016/0303-7207(95)03684-9
  29. Carruba, 1994, Estradiol inhibits growth of hormone non responsive PC3 human prostate cancer cells., Cancer Res, 54, 1190

Cited by

See all 45

Metadata

Authors
Castagnetta, L. A. M., Carruba, G., Traina, A., Granata, O. M., Markus, M., Pavone-Macaluso, M., Blomquist, C. H., & Adamski, J.
Venue
Endocrinology
Published
1997-11-01
Volume
138
Issue
11
Pages
4876-4882
ISSN
  • 0013-7227 (ISSN-L)
  • 1945-7170
OpenAlex
W2060524703
Cited by
45
References
7
FWCI
2.35
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Expression of Different 17β-Hydroxysteroid Dehydrogenase Types and Their Activities in Human Prostate Cancer Cells*. https://app.cochat.ai/papers/10.1210/endo.138.11.5497
The paper
Castagnetta, L. A. M., Carruba, G., Traina, A., Granata, O. M., Markus, M., Pavone-Macaluso, M., Blomquist, C. H., & Adamski, J. (1997). Expression of Different 17β-Hydroxysteroid Dehydrogenase Types and Their Activities in Human Prostate Cancer Cells*. Endocrinology. https://doi.org/10.1210/endo.138.11.5497

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.